Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2018

01-01-2018 | Concise Research Letters

Missed Doses of Venous Thromboembolism (VTE) Prophylaxis at Community Hospitals: Cause for Alarm

Authors: Brandyn D. Lau, MPH, CPH, Michael B. Streiff, MD, FACP, Peggy S. Kraus, PharmD, CACP, Deborah B. Hobson, BSN, Dauryne L. Shaffer, MSN, Jonathan K. Aboagye, MBChB, MPH, Peter J. Pronovost, MD, PhD, Elliott R. Haut, MD, PhD, FACS

Published in: Journal of General Internal Medicine | Issue 1/2018

Login to get access

Excerpt

Venous thromboembolism (VTE) is a leading cause of potentially preventable harm. Randomized controlled trials have demonstrated that VTE prophylaxis, when administered completely, significantly reduces the risk for deep vein thrombosis, pulmonary embolism (PE), and fatal PE.1
Literature
1.
go back to reference Streiff MB, Lau BD. Thromboprophylaxis in nonsurgical patients. Hematology Am Soc Hematol Educ Program. 2012;2012:631–7.PubMed Streiff MB, Lau BD. Thromboprophylaxis in nonsurgical patients. Hematology Am Soc Hematol Educ Program. 2012;2012:631–7.PubMed
2.
go back to reference Lau BD, Haut ER. Practices to prevent venous thromboembolism: a brief review. BMJ Qual Saf. 2014;23(3):187–95.CrossRef Lau BD, Haut ER. Practices to prevent venous thromboembolism: a brief review. BMJ Qual Saf. 2014;23(3):187–95.CrossRef
3.
go back to reference Fanikos J, Stevens LA, Labreche M, et al. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med. 2010;123(6):536–41.CrossRef Fanikos J, Stevens LA, Labreche M, et al. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med. 2010;123(6):536–41.CrossRef
4.
go back to reference Shermock KM, Lau BD, Haut ER, et al. Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: Implications for novel intervention strategies. PLoS ONE. 2013;8(6):e66311.CrossRef Shermock KM, Lau BD, Haut ER, et al. Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: Implications for novel intervention strategies. PLoS ONE. 2013;8(6):e66311.CrossRef
5.
go back to reference Haut ER, Lau BD, Kraus PS, et al. Preventability of hospital-acquired venous thromboembolism. JAMA Surg. 2015;150(9):912.CrossRef Haut ER, Lau BD, Kraus PS, et al. Preventability of hospital-acquired venous thromboembolism. JAMA Surg. 2015;150(9):912.CrossRef
6.
go back to reference Elder S, Hobson DB, Rand CS, et al. Hidden barriers to delivery of pharmacological venous thromboembolism prophylaxis: The role of nursing beliefs and practices. J Patient Saf. 2016;12(2):63–8.CrossRef Elder S, Hobson DB, Rand CS, et al. Hidden barriers to delivery of pharmacological venous thromboembolism prophylaxis: The role of nursing beliefs and practices. J Patient Saf. 2016;12(2):63–8.CrossRef
Metadata
Title
Missed Doses of Venous Thromboembolism (VTE) Prophylaxis at Community Hospitals: Cause for Alarm
Authors
Brandyn D. Lau, MPH, CPH
Michael B. Streiff, MD, FACP
Peggy S. Kraus, PharmD, CACP
Deborah B. Hobson, BSN
Dauryne L. Shaffer, MSN
Jonathan K. Aboagye, MBChB, MPH
Peter J. Pronovost, MD, PhD
Elliott R. Haut, MD, PhD, FACS
Publication date
01-01-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4203-y

Other articles of this Issue 1/2018

Journal of General Internal Medicine 1/2018 Go to the issue

Innovation and Improvement: Innovations in Medical Education

Warm Handoffs: a Novel Strategy to Improve End-of-Rotation Care Transitions

Innovation and Improvement: Innovations in Medical Education

Integration of Primary Care and Psychiatry: A New Paradigm for Medical Student Clerkships

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.